NCT06474091Enrolling by invitation
Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
This study explores the potential value of a new blood test approach to detect measurable residual disease or early recurrence/progression in patients with cholangiocarcinoma.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 19 Jun 2024
- Start date
- 8 May 2024
- Primary completion date
- 8 May 2029
- Lead sponsor
- Mayo Clinic
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06474091
What you commit to
- Study type: Observational
- Planned participants: 100
- From 8 May 2024 to the primary completion date, 8 May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patent has known primary cancer outside of the bile ducts within the last 3 years prior to blood collection (not including basal cell or squamous cell skin cancers, indolent cancer not requiring treatment within 3 years i.e. kidney, prostate or thyroid being observed)
- Patient has had surgery to remove current target pathology completely or partially
- Patient has undergone any prior radiation therapy to target lesion prior to blood collection
- Patient has received chemotherapy class drugs in the 3 years prior to blood collection
- Patient has had any transplants prior to blood collection
Other illness
- Patient has metastatic disease involving other organs (excluding lymph node)
Other
- Current target pathology is a recurrence
Who the study is looking for
- Patient has a suspected or clinical diagnosis of cholangiocarcinoma and under evaluation for surgical intervention with intent to cure
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.